These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36065707)

  • 1. [Baroreflex ActivationTherapy for Heart Failure].
    Xu Y; Yang YJ; Guo J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):717-721. PubMed ID: 36065707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
    Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.
    Gronda E; Seravalle G; Brambilla G; Costantino G; Casini A; Alsheraei A; Lovett EG; Mancia G; Grassi G
    Eur J Heart Fail; 2014 Sep; 16(9):977-83. PubMed ID: 25067799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure.
    Gronda E; Vanoli E
    Curr Heart Fail Rep; 2016 Dec; 13(6):273-280. PubMed ID: 27854009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baroreflex activation for the treatment of heart failure.
    Sabbah HN
    Curr Cardiol Rep; 2012 Jun; 14(3):326-33. PubMed ID: 22528555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.
    Bisognano J; Schneider JE; Davies S; Ohsfeldt RL; Galle E; Stojanovic I; Deering TF; Lindenfeld J; Zile MR
    BMC Cardiovasc Disord; 2021 Mar; 21(1):155. PubMed ID: 33771104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
    Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction.
    Halbach M; Hickethier T; Madershahian N; Müller-Ehmsen J
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1465-9. PubMed ID: 25382103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.
    Dell'Oro R; Gronda E; Seravalle G; Costantino G; Alberti L; Baronio B; Staine T; Vanoli E; Mancia G; Grassi G
    J Hypertens; 2017 Dec; 35(12):2532-2536. PubMed ID: 28816745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights.
    Grassi G; Brambilla G; Pizzalla DP; Seravalle G
    Curr Hypertens Rep; 2016 Aug; 18(8):60. PubMed ID: 27334011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic Modulation in Heart Failure: Ready for Prime Time?
    Dunlap ME; Bhardwaj A; Hauptman PJ
    Curr Cardiol Rep; 2015 Nov; 17(11):103. PubMed ID: 26384110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].
    Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
    Herz; 2015 Nov; 40(7):959-65. PubMed ID: 26525523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction.
    Georgakopoulos D; Little WC; Abraham WT; Weaver FA; Zile MR
    J Card Fail; 2011 Feb; 17(2):167-78. PubMed ID: 21300307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
    Weaver FA; Abraham WT; Little WC; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Madershahian N; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Zile MR
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):320-328. PubMed ID: 28043438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction.
    Floras JS; Ponikowski P
    Eur Heart J; 2015 Aug; 36(30):1974-82b. PubMed ID: 25975657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional and device-based autonomic modulation in heart failure.
    Shen MJ; Zipes DP
    Heart Fail Clin; 2015 Apr; 11(2):337-48. PubMed ID: 25834979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-pharmacological modulation of the autonomic tone to treat heart failure.
    Singh JP; Kandala J; Camm AJ
    Eur Heart J; 2014 Jan; 35(2):77-85. PubMed ID: 24174128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].
    Wallbach M; Koziolek MJ; Wachter R
    Internist (Berl); 2018 Oct; 59(10):1011-1020. PubMed ID: 30182192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction.
    Gronda E; Francis D; Zannad F; Hamm C; Brugada J; Vanoli E
    J Cardiovasc Med (Hagerstown); 2017 Sep; 18(9):641-649. PubMed ID: 28737621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.